Peripheral Vascular Disease (PVD) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

New Data Reinforces Effectiveness of Dual Pathway Inhibition with Xarelto plus Aspirin in Patients with Coronary Artery Disease and/or Peripheral Artery Disease
RARITAN, N.J., May 23, 2022. Findings from the XARELTO (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and the XARELTO in Combination with Acetylsalicylic Acid (XATOA) registry have been published in the European Society... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - May 23, 2022 Category: Pharmaceuticals Source Type: clinical trials

A New Heat Therapy Device for Home-based Leg Heating in Patients With Lower-extremity Peripheral Artery Disease: a Pilot Study
Conditions: Peripheral Arterial Disease; Intermittent Claudication Intervention: Device: Home-based leg heat therapy Sponsors: Purdue University; Aquilo Sports Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2022 Category: Research Source Type: clinical trials

Angio-seal VIP Versus Perclose ProGlide for Closure of the Femoral Artery in Peripheral Vascular Disease
Conditions: Peripheral Vascular Diseases; Percutaneous Intervention Via Femoral Artery Interventions: Device: Perclose ProGlide; Device: Angio-seal VIP Sponsor: Xiongjing Jiang Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2022 Category: Research Source Type: clinical trials